Actually it is beyond a Phase III asset as it made it all the way to approval (in France).
One thing I think investors should look into in detail is Phase III breast cancer trial paper [1]. I have attached it, because I don’t think a lot of people have had a chance to read it.
1. J. Natl. Cancer Inst. 1991 Cowan.pdf
General Comments / Chat, page-82
- There are more pages in this discussion • 10,854 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
0.020(1.38%) |
Mkt cap ! $243.8M | |||
| Open | High | Low | Value | Volume |
| $1.47 | $1.47 | $1.47 | $12.40K | 8.441K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5391 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.48 | 100 | 1 |
View Market Depth
| Last trade - 10.06am 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.49 |
Change
0.020 ( 1.71 %) |
||||
| Open | High | Low | Volume | ||
| $1.49 | $1.49 | $1.49 | 1228 | ||
| Last updated 10.26am 27/05/2024 ? | |||||
| RAC (ASX) Chart |